Dow AgroSciences and TeselaGen Expanding Advanced Biodesign Platform for Ag
August 28 2017 - 8:00AM
Business Wire
Innovative use of molecular design technology is essential for
discovering and developing new agricultural products at a faster
pace. Today, TeselaGen Biotechnology Inc., and Dow AgroSciences,
LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE:
DOW), announced they have entered a new phase in their
collaboration to produce a state-of-the-art biological design
automation platform that can speed discovery work. The companies
began collaborating in 2016.
The current collaboration yielded significant results with a new
design platform, which has helped scientists increase the flow of
potential discovery leads tenfold. The new phase of the
collaboration builds on this order of magnitude increase in
research productivity and extends the platform with a powerful
software module for industrial-scale cloning. In building a
flexible modular platform and not a custom solution, the companies
are rigorous about building software modules that adhere to a
strict design-build-test methodology with a strong emphasis on
repeatability and architecture suitable for machine learning.
“Implementing a secure computational environment to design and
create molecular biology research information will accelerate our
scientists’ efforts to find new crop protection and seed products
for farmers around the world,” said Otto Folkerts, Ph.D., Research
Fellow, Dow AgroSciences.
“TeselaGen is building a platform that automates and optimizes
protocol generation and information flow for biomanufacturing. Our
hypothesis is that biotechnology is essentially an information
technology. Improving the flow, handling and interpretation of
information is a tremendous accelerant for biotech product
development,” said Dr. Michael Fero, Chief Executive Officer,
TeselaGen.
Terms of the collaboration were not disclosed.
About Dow AgroSciences
Dow AgroSciences discovers, develops, and brings to market crop
protection and plant biotechnology solutions for the growing world.
Based in Indianapolis, Indiana, USA, Dow AgroSciences is a wholly
owned subsidiary of The Dow Chemical Company and had annual global
sales of $6.2 billion in 2016. Learn more at www.dowagro.com.
Follow Dow AgroSciences on Facebook, Twitter, LinkedIn, and
Google+, or subscribe to our News Release RSS Feed.
About TeselaGen
TeselaGen builds secure enterprise quality software platforms
for designing, building and precision editing DNA, enabling the
development of vaccines, biologic medicines, and sustainably
sourced chemicals. TeselaGen is privately held and is based in the
software hub of San Francisco, CA. The company has received early
recognition in the form of four US National Science Foundation
funding awards, a US Department of Energy funding award and a
Bio-IT World Best Practices Award. TeselaGen uses its proprietary
Synthetic Evolution® technology for efficient rapid prototyping and
editing of recombinant molecules. Follow TeselaGen on Facebook,
Twitter, LinkedIn, and Google+, and learn more at
teselagen.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170828005034/en/
TeselaGenMichael Fero, 650-387-5932mike.fero@teselagen.comorDow
AgroSciencesKenda Resler Friend, 317-337-4743kresler@dow.com
Dow (NYSE:DOW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dow (NYSE:DOW)
Historical Stock Chart
From Apr 2023 to Apr 2024